PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

How neurotransmitters work together to detect and discriminate odors

2023-11-28
(Press-News.org) A longstanding hypothesis in neurobiology was that a single neuron releases a single type of neurotransmitter, a molecule used by neurons to communicate with one another. In recent decades, several neurons have been found to release more than one neurotransmitter. This phenomenon called co-transmission is increasingly gaining recognition as a powerful and versatile molecular mechanism useful for the dynamic regulation of diverse neural circuits. However, precisely how co-transmission affects the firing of target neurons, and the overall behavior of an animal, remains to be elucidated.

A recent study in the laboratory of Dr. Benjamin Arenkiel, professor at Baylor College of Medicine and a principal investigator at the Jan and Dan Duncan Neurological Research Institute (Duncan NRI) has dissected how co-transmission of two neurotransmitters – gamma-aminobutyric acid (GABA) and dopamine – from a specific group of olfactory bulb neurons modulates the activity of the entire circuit. It was published in Cell Reports.

Dissecting co-transmission in sSAC neurons of the mammalian olfactory bulb

GABA and dopamine are both present and co-transmitted in many brain cells. The Arenkiel lab focused on a type of olfactory inhibitory neurons called the superficial short axon cells (sSACs) that receive inputs from various olfactory sensory neurons.

“To understand the role of sSACs in detecting and discriminating odors, we specifically blocked the release of GABA or dopamine from these neurons,” lead author Dr. Ariel Lyons-Warren, a clinical scientist in the Arenkiel lab, said. “We used a well-established genetic technique to generate mouse models that lacked the ability to release either GABA or dopamine or both.

Using a behavioral assay that hinges on the innate ability of mice to detect hidden food, they found that mice that lack both GABA and dopamine were unable to detect odors. Inhibiting either of these neurotransmitters individually did not lead to any impairments in odor detection. However, mice in which either GABA or dopamine release was blocked could not differentiate between pairs of molecularly similar odors that normal mice could easily tell apart.

“Based on these observations, we conclude that both GABA and dopamine are individually sufficient to detect odors whereas they likely act cooperatively with one another to discriminate similar odors,” added Dr. Lyons-Warren.

Uncovering how co-transmission helps in odor detection and discrimination

The sSACs receive inputs from various olfactory sensory neurons and send those signals to tufted cells and mitral cells, the primary output neurons that synapse with granule cell neurons present in the deepest layer of the olfactory bulb. Thus, sSACs are a part of the initial circuitry in the olfactory bulb that helps detect, decode, and process olfactory information that the brain receives from the external environment.

To understand the underlying neural circuits and mechanisms involved in the detection and discrimination of odors, the Arenkiel team set about finding the targets of GABA and dopamine in sSACs.

First, they found GABA and D1 dopamine receptors, which are present throughout the olfactory bulb and importantly, on the known and new targets of sSACs were involved in odor detection.

Using Channelrhodopsin-assisted circuit mapping (CRACM), they found that although sSACs are connected to external tufted cells via both GABA and dopamine receptors, they only release dopamine to granule cells. Furthermore, they found that impaired release of sSAC GABA or dopamine impacts mitral cell firing frequency, which in turn increases the number of glomeruli that respond to a given odor and leads to reduced odor discrimination.

“This study provides crucial mechanistic insights into co-transmission specifically in the context of olfaction and shows how this type of neuromodulation sculpts distinct responses to sensory inputs,” Dr. Arenkiel, who is also a McNair Scholar, said. “It also nicely illustrates how co-transmission allows a single cell type to mount varied responses to the same stimuli by differentially modulating different target neurons. Given that co-transmission is now known to occur in various brain cell types, this will serve as the foundation for further explorations on neuromodulatory effects of multiple neurotransmitters in olfaction as well as in other sensory processes.”

------------------------------------------------------------------------------------------------------------

Others involved in the study were Evelyne Tantry, Elizabeth Moss, Mikhail Kochukov, Benjamin Belfort, Joshua Ortiz-Guzman, and Zachary Freyberg. They are affiliated with one or more of the following institutions: the Jan and Dan Duncan Neurological Research Institute at Texas Children’s Hospital, Baylor College of Medicine, and the University of Pittsburgh. The study was funded by the National Institutes of Health, McNair Medical Institute at The Robert and Janice McNair Foundation, and the Department of Defense.

 

END


ELSE PRESS RELEASES FROM THIS DATE:

ChargeX Consortium recommends common EV charging station error codes

ChargeX Consortium recommends common EV charging station error codes
2023-11-28
New shared language will facilitate faster service, improve EV user experience The National Charging Experience Consortium (ChargeX) has released a report that recommends 26 common electric vehicle (EV) charging error codes to enable faster error reporting, diagnostics and resolution within the EV charging industry. Ultimately, the codes would improve the U.S. charging experience. The ChargeX Consortium is a collaboration between U.S. Department of Energy national laboratories, EV charging industry experts, consumer advocates and other stakeholders. The Recommendations for Minimum Required Error Codes report aims to reduce confusion between charger manufacturers, EV manufacturers and ...

Ending the HIV epidemic may require addressing “everyday” discrimination

2023-11-28
Latino sexual minority men who experience racial, ethnic and sexual prejudice are more likely to delay HIV testing, complicating efforts to end the more than 40-year epidemic, according to a new Rutgers study. “Total HIV infection rates in the United States are stabilizing, which is good news,” said Gabriel Robles, an assistant professor at the Rutgers School of Social Work and coauthor of the paper published in the journal AIDS Education and Prevention. “What’s bad is that the trend for some subgroups, including some Latino/x sexual minority men, is going in the opposite direction. Our study offers ...

Anonymous $10 million gift to Henry Ford Health establishes lung cancer tissue repository, bolsters research

2023-11-28
As Lung Cancer Awareness Month comes to a close, Henry Ford Health is proud to announce it has received an anonymous gift of $10 million, which is poised to significantly advance lung cancer research at Henry Ford Cancer. This transformative gift has enabled Henry Ford to establish a new lung cancer tissue biorepository, which is a facility that catalogs and stores biological samples for research. These samples – in this case, lung cancer tissue – are crucial for scientists who are studying ...

RCSI researchers develop material that reduces bacterial infection and speeds up bone healing

RCSI researchers develop material that reduces bacterial infection and speeds up bone healing
2023-11-28
28 November 2023: Researchers at RCSI University of Medicine and Health Sciences and Advanced Materials and Bioengineering Research Centre (AMBER) have developed a new surgical implant that has the potential to transform the treatment of complex bone infections. When implanted on an injured or infected bone, the material can not only speed up bone healing, it also reduces the risk of infections without the need for traditional antibiotics.  The newly published paper in the journal Advanced Materials, tackles the complex clinical problem of bone infection, ...

Contrast sensitivity of ON and OFF human retinal pathways in myopia

2023-11-28
Across the entire animal kingdom, visual images are processed by two major neuronal pathways that extract light and dark stimuli from visual scenes – ON (light on) and OFF (light off) pathways. Light stimuli are brighter than their background like a white cloud in a gray sky whereas dark stimuli are darker than the background like a black bird in a blue sky. The two pathways can extract stimuli with different contrasts but some pathways are more sensitive than others. In carnivores and rodents, ON pathways are more sensitive ...

DFW air quality continues to miss EPA goals for safety

DFW air quality continues to miss EPA goals for safety
2023-11-28
Air quality in the Dallas-Fort Worth metropolitan area continues to miss safety levels set by the Environmental Protection Agency (EPA) and is unlikely to meet EPA goals anytime soon, according to new research from The University of Texas at Arlington. Purnendu “Sandy” Dasgupta, professor of chemistry and biochemistry and the Hamish Small Chair of Ion Analysis at The University of Texas at Arlington, said the region’s low population density, lack of widespread public transportation and reliance on cars contribute to its poor air quality. Its ozone values have exceeded safety levels set by the EPA for the last 20 years. “Compared ...

Many owners see little value in storing their firearms securely

2023-11-28
With more than 400 million privately owned firearms in circulation across the United States, gun violence prevention efforts have emphasized secure firearm storage as a method for preventing injury and death. But some owners may not see the value in doing so, according to Rutgers researchers. Despite evidence that secure storage can effectively reduce the risk of suicide and unintentional shootings, many firearm owners typically keep at least one firearm stored loaded and unlocked, quickly accessible in case of home invasion. ...

PCORI approves $80.5 million for health research using novel approaches to tackle social and clinical care factors that contribute to maternal health inequities

PCORI approves $80.5 million for health research using novel approaches to tackle social and clinical care factors that contribute to maternal health inequities
2023-11-28
WASHINGTON, D.C. – The Patient-Centered Outcomes Research Institute (PCORI) today announced funding awards totaling $80.5 million to support four new, ambitious patient-centered comparative clinical effectiveness research (CER) studies focused on both the health care and social factors that contribute to inequities in maternal morbidity and mortality. The trials are among 30 CER studies and related projects recently approved for PCORI funding.    Awarded through an innovative PCORI funding opportunity known as Partner for its focus on partnering research institutions and community organizations ...

Ohio State receives $14 million to study optimal aspirin therapy in pregnancy

2023-11-28
COLUMBUS, Ohio – A research team at The Ohio State University Wexner Medical Center and College of Medicine has been approved for a $14 million award from the Patient-Centered Outcomes Research Institute (PCORI) to study whether a higher daily dose of aspirin is more effective in decreasing the risk of dangerous blood pressure complications among some pregnant people. During pregnancy, people are at risk of developing preeclampsia and gestational hypertension. Both disorders are characterized by high blood pressure and bring with them the potential for injury to the brain, lungs, kidneys and liver. These hypertensive disorders ...

University of Colorado Department of Medicine cardiologist lands $7 million funding award for nationwide study on improving heart-failure treatment

2023-11-28
Larry Allen, MD, chief of the Division of Cardiology at the University of Colorado School of Medicine, will receive a funding award for a nationwide study that he hopes will lead to more heart-failure patients getting the life-saving medications they need. The $7 million in support, announced Nov. 28, is from the nonprofit Patient-Centered Outcomes Research Institute (PCORI), the leading U.S. funder of comparative clinical effectiveness research centered on patients. Allen, a professor of cardiology in the CU Department of Medicine, says the funding award includes $2.5 million in direct support to CU, another $2.5 million to four other ...

LAST 30 PRESS RELEASES:

Black youth, especially Black girls, use mental health services less than their White peers

Canada must protect youth from sports betting advertising

First-in-human trial shows promising results for DLL3-targeted antibody-drug conjugate SHR-4849 in relapsed small cell lung cancer

Ifinatamab deruxtecan demonstrates high response rate in previously treated extensive-stage small cell lung cancer: Phase 2 IDeate-Lung01 trial

Higher blood pressure in childhood linked to earlier death from heart disease in adulthood

AI helped older adults report accurate blood pressure readings at home

High blood pressure in childhood and premature cardiovascular disease mortality

Zidesamtinib shows durable responses in ROS1 TKI pre-treated NSCLC, including patients with CNS disease and ROS1 G2032R mutations

Crizotinib fails to improve disease-free survival in resected early-stage ALK+ NSCLC

Ivonescimab plus chemotherapy improves progression-free survival in patients with EGFR+ NSCLC following 3rd-generation EGFR-TKI therapy

FLAURA2 trial shows osimertinib plus chemotherapy improves overall survival in eGFR-mutated advanced NSCLC

Aumolertinib plus chemotherapy improves progression-free survival in NSCLC with EGFR and concomitant tumor suppressor genes: ACROSS 2 phase III study

New antibody-drug conjugate shows promising efficacy in EGFR-mutated NSCLC patients

Iza-Bren in combination with osimertinib shows 100% response rate in EGFR-mutated NSCLC, phase II study finds

COMPEL study shows continuing osimertinib treatment through progression with the addition of chemotherapy improves progression-free survival in EGFR-mutated NSCLC

CheckMate 77T: Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC

Study validates AI lung cancer risk model Sybil in predominantly Black population at urban safety-net hospital

New medication lowered hard-to-control high blood pressure in people with chronic kidney disease

Innovative oncolytic virus and immunotherapy combinations pave the way for advanced cancer treatment

New insights into energy metabolism and immune dynamics could transform head and neck cancer treatment

Pennington Biomedical’s Dr. Steven Heymsfield named LSU Boyd Professor – LSU’s highest faculty honor

Study prompts new theory of human-machine communication

New method calculates rate of gene expression to understand cell fate

Researchers quantify rate of essential evolutionary process in the ocean

Innovation Crossroads companies join forces, awarded U.S. Air Force contract

Using new blood biomarkers, USC researchers find Alzheimer’s disease trial eligibility differs among various populations

Pioneering advances in in vivo CAR T cell production

Natural medicines target tumor vascular microenvironment to inhibit cancer growth

Coral-inspired pill offers a new window into the hidden world of the gut

nTIDE September2025 Jobs Report: Employment for people with disabilities surpasses prior high

[Press-News.org] How neurotransmitters work together to detect and discriminate odors